【摘要】：目的:探索新藥研發(fā)活動(dòng)對(duì)醫(yī)藥制造業(yè)就業(yè)產(chǎn)生影響的作用機(jī)制,對(duì)新藥研發(fā)就業(yè)效應(yīng)進(jìn)行實(shí)證研究,為政府和企業(yè)進(jìn)行新藥研發(fā)管理決策及戰(zhàn)略制定提供參考。方法:以理論研究為基礎(chǔ),結(jié)合醫(yī)藥行業(yè)特性,建立新藥研發(fā)就業(yè)效應(yīng)研究模型,以2004-2012年相關(guān)數(shù)據(jù),檢驗(yàn)?zāi)Ｐ偷暮侠硇?并對(duì)新藥研發(fā)就業(yè)效應(yīng)進(jìn)行定量研究。結(jié)果:1每增加1%的新藥研發(fā)支出,最終將增加就業(yè)量0.135 3%,包括0.394 6%的促進(jìn)效應(yīng)、0.259 3%的擠出效應(yīng),即每年新藥研發(fā)支出每增長(zhǎng)10億元,可以創(chuàng)造約7 900個(gè)就業(yè)崗位,同時(shí)提升醫(yī)藥制造業(yè)人均主營(yíng)業(yè)務(wù)收入約1.1%,多創(chuàng)造約122億產(chǎn)值。2中藥制造業(yè)新藥研發(fā)支出的就業(yè)效應(yīng)、就業(yè)促進(jìn)效應(yīng)、就業(yè)擠出效應(yīng)均高于化學(xué)制藥業(yè),但不同年份之間的差別也大于化學(xué)制藥業(yè)。結(jié)論:1本文建立的研究模型是合理的。2醫(yī)藥制造業(yè)新藥研發(fā)支出對(duì)就業(yè)體現(xiàn)為正向推動(dòng)作用,對(duì)企業(yè)規(guī)模、生產(chǎn)效率也有積極作用。3中藥制造業(yè)新藥研發(fā)支出對(duì)就業(yè)及企業(yè)的發(fā)展效果均優(yōu)于化學(xué)制藥業(yè),但作用效果并不穩(wěn)定。
[Abstract]:Objective: to explore the mechanism of the effect of new drug research and development on the employment of pharmaceutical manufacturing industry, and to provide a reference for the government and enterprises to make new drug research and development management decisions and strategies. Methods: on the basis of theoretical research and combining with the characteristics of pharmaceutical industry, a new drug research model was established to test the rationality of the model based on the relevant data from 2004 to 2012, and to quantitatively study the employment effect of new drug research and development. Results every 1% increase in new drug R & D spending by 1% will eventually increase the employment volume by 0.135 33%, including 0.394 6% promotion effect and 0.259.3% extrusion effect. That is, every 1 billion yuan per year in new drug R & D expenditure can create about 7,900 jobs. At the same time, the per capita main business income of the pharmaceutical manufacturing industry was increased by about 1.1, and the employment effect, the employment promotion effect and the employment crowding out effect of the new drug R & D expenditure of the Chinese medicine manufacturing industry were all higher than those of the chemical pharmaceutical industry. But the difference between different years is also greater than the chemical industry. Conclusion the research model established in this paper is that the rational R & D expenditure of new drugs in pharmaceutical manufacturing industry has a positive effect on employment and has a positive effect on the scale of enterprises. The production efficiency is also positive. 3. The new drug R & D expenditure in the traditional Chinese medicine manufacturing industry is superior to the chemical pharmaceutical industry in terms of employment and the development of enterprises, but the effect is not stable.
【作者單位】： 廣東藥學(xué)院醫(yī)藥商學(xué)院;
【基金】：廣東省教育科學(xué)“十二五”規(guī)劃2013年度課題(2013JK085)
【分類號(hào)】：R95

【參考文獻(xiàn)】

相關(guān)期刊論文 前4條

1 趙利;王振興;李欣;;R&D活動(dòng)的就業(yè)效應(yīng):基于中國(guó)數(shù)據(jù)的實(shí)證分析[J];東岳論叢;2011年11期

2 黃r，

本文編號(hào)：2127396